2131 Efficacy and safety of nab-paclitaxel (nab-P) in patients (pts) with previously treated metastatic colorectal cancer (mCRC): The phase II COLO-001 trial

Authors :: L. Li
Astrid Lièvre
Antoine Adenis
Jaafar Bennouna
M. Ducreux
D. McGovern
T. Conroy
Fabienne Portales
A. Romano
Source :: European Journal of Cancer. 51:S376
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Colorectal cancer
Internal medicine
medicine
In patient
Previously treated
business
medicine.disease
Nab-paclitaxel

Tools